Cargando…

Biosimilar switching – current state of knowledge

Evidence from over 10 years of clinical experience demonstrates that biosimilar medicines approved in the European Union can be used for all their registered indications as safely as their originators and with no negative impact on therapeutic efficacy. The debate on the use of biosimilars in rheuma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiland, Piotr, Batko, Bogdan, Brzosko, Marek, Kucharz, Eugeniusz J., Samborski, Włodzimierz, Świerkot, Jerzy, Więsik-Szewczyk, Ewa, Feldman, Julia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie 2018
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142020/ https://www.ncbi.nlm.nih.gov/pubmed/30237628 http://dx.doi.org/10.5114/reum.2018.77975

Ejemplares similares

Real-World Data from a Multi-Center Study: Insights to Psoriatic Arthritis Care
por: Batko, Bogdan, et al.
Publicado: (2021)

Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for Rheumatology
por: Kucharz, Eugeniusz J., et al.
Publicado: (2018)

Methotrexate treatment for rheumatoid arthritis in Poland: Retrospective analysis of patients in routine clinical practice
por: Świerkot, Jerzy, et al.
Publicado: (2018)

Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study
por: Batko, Bogdan, et al.
Publicado: (2017)

Novel Approach to the Treatment in Rheumatic Diseases: From Molecule to Value for Patient
por: Mojs, Ewa, et al.
Publicado: (2018)

Monogenic autoinflammatory diseases in adults – a challenge to rheumatologic practice at the onset of the Polish national programme of interleukin 1 inhibitor treatment
por: Milchert, Marcin, et al.
Publicado: (2019)

Results from Polish Spondyloarthritis Initiative registry (PolSPI) – methodology and data from – the first year of observation
por: Guła, Zofia, et al.
Publicado: (2017)

Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
por: Mysler, Eduardo, et al.
Publicado: (2021)

Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis
por: Świerkot, Jerzy, et al.
Publicado: (2015)

Management of rheumatoid arthritis in Poland – where daily practice might not always meet evidence-based guidelines
por: Batko, Bogdan, et al.
Publicado: (2019)

Biosimilars: To switch or not to switch – that is the question
por: Szekanecz, Zoltán
Publicado: (2020)

Alterations in Both the Activatory and Inhibitory Potential of Peripheral Blood CD4+ T Cells in Rheumatoid Arthritis Patients Correlate with Disease Progression
por: Kosmaczewska, Agata, et al.
Publicado: (2013)

Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis
por: Iwaszko, Milena, et al.
Publicado: (2018)

Addendum: Iwaszko et al., Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis. Genes 2018, 9, 64
por: Iwaszko, Milena, et al.
Publicado: (2018)

Serum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: correlation to disease activity
por: Mielnik, Pawel, et al.
Publicado: (2010)

Interleukin 1 inhibitors in monogenic autoinflammatory diseases – one size does not fit all
por: Więsik-Szewczyk, Ewa
Publicado: (2021)

Classification criteria for secondary Sjögren’s syndrome. Current state of knowledge
por: Sebastian, Agata, et al.
Publicado: (2019)

Switch from reference etanercept to SDZ ETN, an etanercept biosimilar, does not impact efficacy, safety, and immunogenicity of etanercept in patients with moderate-to-severe rheumatoid arthritis: 48-week results from the phase III, randomized, double-blind EQUIRA study
por: Jaworski, Janusz, et al.
Publicado: (2019)

Polymorphisms within Genes Involved in Regulation of the NF-κB Pathway in Patients with Rheumatoid Arthritis
por: Gębura, Katarzyna, et al.
Publicado: (2017)

Relationship Between Interleukin-6 −174G/C Genetic Variant and Efficacy of Methotrexate Treatment in Psoriatic Arthritis Patients
por: Sokolik, Renata, et al.
Publicado: (2021)

Factors associated with quality of life in systemic sclerosis: a cross-sectional study
por: Sierakowska, Matylda, et al.
Publicado: (2019)

Budget impact analysis and treatment availability with biosimilar TNF inhibitors in rheumatic diseases in Poland: real-world evidence using a nationwide database
por: Stajszczyk, Marcin, et al.
Publicado: (2023)

Switching from Biosimilar to Biosimilar Adalimumab, Including Multiple Switching, in Crohn’s Disease: A Prospective Study
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2021)

Tumor necrosis factor alpha inhibitors and demyelinating disease: what is behind it?
por: Kucharz, Eugeniusz Józef, et al.
Publicado: (2021)

In memoriam Professor Ugo Efisio Francesco Carcassi
por: Kucharz, Eugeniusz J.
Publicado: (2016)

The 33(rd) World Congress of Internal Medicine: Nusa Dua, Indonesia, August 22–25, 2016
por: Kucharz, Eugeniusz J.
Publicado: (2016)

Sesquicentennial of the birth of Edmund Faustinus Biernacki, a discoverer of the erythrocyte sedimentation rate
por: Kucharz, Eugeniusz J.
Publicado: (2017)

The 11(th) Central European Congress of Rheumatology: Prague, December 8–10, 2016
por: Kucharz, Eugeniusz J.
Publicado: (2017)

Medical eponyms from linguistic and historical points of view
por: Kucharz, Eugeniusz Józï
Publicado: (2020)

Hit two birds with one stone: why crystalline glucosamine sulphate used for osteoarthritis medication is beneficial for patients with risk of cardiovascular disorders
por: Kucharz, Eugeniusz J.
Publicado: (2019)

Osseous manifestations of sarcoidosis
por: Kucharz, Eugeniusz Józef
Publicado: (2020)

A case report of pregnancy in a patient with common variable immunodeficiency emphasizing the need for personalized immunoglobulin replacement
por: Więsik-Szewczyk, Ewa, et al.
Publicado: (2018)

From infections to autoimmunity: Diagnostic challenges in common variable immunodeficiency
por: Więsik-Szewczyk, Ewa, et al.
Publicado: (2020)

Cytokine profiles in axial spondyloarthritis
por: Madej, Marta, et al.
Publicado: (2015)

Current perspectives on biosimilars
por: Agbogbo, Frank K., et al.
Publicado: (2019)

IL-17A, IL-17F and IL-23R Gene Polymorphisms in Polish Patients with Rheumatoid Arthritis
por: Bogunia-Kubik, Katarzyna, et al.
Publicado: (2014)

Associations between Manual Abilities, Gross Motor Function, Epilepsy, and Mental Capacity in Children with Cerebral Palsy
por: GAJEWSKA, Ewa, et al.
Publicado: (2014)

Serum angiostatin and endostatin levels in patients with granulomatosis with polyangiitis and immune complex small vessel vasculitis
por: Kotulska-Kucharz, Anna, et al.
Publicado: (2018)

Ocular manifestations in patients with systemic sclerosis
por: Kozikowska, Małgorzata, et al.
Publicado: (2020)

The Challenges of Switching Therapies in an Evolving Multiple Biosimilars Landscape: A Narrative Review of Current Evidence
por: Feagan, Brian G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fvtpk1pof45ft5vlu9i8ikj335